Seattle Cancer Care Alliance (SCCA)

825 Eastlake Avenue East
Seattle, Washington 98109

We've found

3 trials

at this facility

A Combination Study of PF-04449913 (Glasdegib) and Azacitidine In Untreated MDS, AML and CMML Patients

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Seattle, WA

Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Seattle, WA

An Open-Label Study of Parsaclisib in Relapsed or Refractory Follicular Lymphoma (CITADEL-203)

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Seattle, WA

Use our guide to learn which trials are right for you!